In a commentary published by the North Carolina Medical Journal, Mary E. Klotman, MD, associate vice president for health affairs and dean of the School of Medicine, and Michael Pencina, PhD, Duke Health’s chief data scientist and vice dean for data science, describe how academic medical centers can maximize their potential and take a leading role in the responsible implementation of artificial intelligence in health care.

Temple Grandin is a Distinguished Professor of Animal Science at Colorado State University, is a renowned author and speaker on both farm animal welfare and her lived experience as an autistic person.

Thanks to a generous grant from The Duke Endowment, the Office of Le Well in the Duke University School of Medicine (SOM) will undertake a project designed to help students succeed and thrive in their clinical learning programs.

Following a thorough external review of the department and its leadership, Gary Faerber, MD, has been named chair of the Department of Urology in the School of Medicine, starting July 1, 2024.&nbsp

James Davis, MD, was a third-year medical student when he realized he wanted to help people beat tobacco addiction. Today, he leads one of the largest smoking cessation programs in the United States. The program, called Quit at Duke, includes 12 specially trained providers and helps more than 6,000 people each year.

Christine Eyler, MD, PhD, Butler Harris Assistant Professor in Radiation Oncology, is one of 15 scientists nationwide

The Foxes have established a generous bequest to support Duke University School of Medicine’s Medical Scientist Training Program.

When James B. Duke signed the indenture of trust that transformed Trinity College into Duke University, he expressed his wish that the new university would include a school of medicine. His goal was to improve access to quality health care in North Carolina. He achieved that, and much more. Over the past 100 years, the School of Medicine has grown from a visionary philanthropist’s dream to the position it holds as one of the world’s premier academic health institutions. The school’s story is one of excellence and innovation in health professions education, world-class patient care, biomedical research, and community partnership.

Ralph Snyderman is chancellor emeritus of Duke University and James B. Duke Distinguished Professor of Medicine. He was dean of the School of Medicine from 1989-1999 and chancellor for health affairs from 1989-2004. He currently serves as executive director of the Duke Center for Personalized Health Care. He reflects on his eventful tenure as dean, which saw the creation of the Duke University Health System, Duke Clinical Research Institute, and other initiatives that positioned Duke as one of the nation’s most innovative and important academic health centers.

Edward Holmes was vice chancellor for academic affairs and dean of the School of Medicine from 1999-2000 and now serves as CEO and president of the Sanford Consortium for Regenerative Medicine, vice chancellor and dean emeritus of University of San Diego Health Sciences, and Distinguished Professor at the University of California. During his time as dean, he says, he worked to build deeper and more effective collaborations not only within the health system but across the rest of campus — efforts that, among other things, helped elevate Duke to a leading position in the field of genome sciences.